logo transparent gif
top_left_edge top_white_spacer top_right_edge
Home Latest Forum Topics MyCorner - Personal Stocks Porfolio Stock Lists Forex Investor Insights Investment News Investor Research & Links Dynamic Stock Charting FREE Registration About Us top spacer top spacer
 User Password Auto-Login
Enter Stock
 
righttip
branding

Return

IX Biopharma

42C

0.048

No Change

GroupCash
CashSingapore Dollar

 

TRADING INFO


Open
0.048
Buy
0.045
Sell
0.05
High
0.048
Low
0.048
Previous Close
0.048
Volume(K)
28.8
Buy Volume(K)
100.0
Sell Volume(K)
5.0

KEY STOCK INFOUpdated: 16 Apr 2024


PE Ratio (FY)
NA
Dividend Yield % (FY)
-
Price to Book Ratio
-
Market Cap ($million)
-
Enterprise Value ($million)
-
52 Weeks High
0.1
52 Weeks Low
0.035
RSI
50.19 ( No Info )
Williams %R
-47.37 ( No Info )

 

COMPANY INFORMATION Updated: 13 Apr 2024 Financial Info by


SIC
IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES
Address
20 COLLYER QUAY, #11-07 SINGAPORE 049319
Phone
(65) 6235 2170
Fax
(65) 8928 8467
Profile
The principal activities of the Company are the development, manufacture and commercialisation of innovative therapies for the treatment of acute and breakthrough pain, and male erectile dysfunction.
AUDITOR
PRICEWATERHOUSECOOPERS LLP

 

FINANICALS INFORMATION All values in $millions


Financial Year
Jun 30, 2022
Jun 30, 2023
Jun 30, 2023
Currency
SGD
SGD
SGD
KEY RATIOS
FY 2022
FY 2023
FY 2023

Operating Margin(%)
-27.081
-159.564
-159.564
Return on Equity Capital(%)
-29.235
-54.023
-54.023
Net Profit Margin(%)
-31.953
-162.608
-162.608
Current Ratio
2.144
1.53
1.53
Debt to Capital at Book
0.154
0.174
0.174
INCOME STATEMENT
FY 2022
FY 2023
FY 2023

EBITDA
2.33
-7.48
-7.48
EBIT
1.27
-8.41
-6.67
Net Profit
-4.6
-9.62
-9.62
Ordinary Dividend
0
0
0
BALANCE SHEET
FY 2022
FY 2023
FY 2023

Intangibles
0.35
1.47
0.29
Fixed Assets
7.5
7.23
7.23
Long Term Investments
0
0
0.19
Stock/Inventories
0.91
0.96
0.96
Cash
13.49
6.52
6.52
Current Liabilities
7.86
7.17
7.17
Long Term Debt
0.88
0.57
0.57
Provisions
0.04
0.04
0.04
Minorities
0
0
0
Total Shareholder Equity
19.74
15.85
15.85
PER SHARE INFO
FY 2022
FY 2023
FY 2023

EBITDA per share
0.003
-0.01
-0.01
EBIT per share
-0.005
-0.013
-0.013
Profit Per Share
-0.006
-0.013
-0.013
Book Value Per Share
0.026
0.019
0.02

 

 


Intraday Chart




ShareJunction Version: 27 Nov 2020 ver- All Rights Reserved. Copyright ShareJunction Pte. Ltd. Disclaimer: All prices from are delayed. ShareJunction does not provide you with any financial advice. We are not into the business of providing any investment advice. See our Terms and Conditions and Privacy Policy of using this website. Data is delayed for varying periods of time depending on the exchange, but for at least 15 minutes. Copyright SIX Financial Information Ltd. and its licensors. All Rights reserved. Further distribution and use by third parties prohibited. SIX Financial Information and its licensors make no warranty for information displayed and accept no liability for data and prices. SIX Financial Information reserves the right to adapt and/or alter this website at any time without prior notice.

Web design by FoundationFlux.